Ortho Dermatologics


Valeant Pharmaceuticals’ ׁ(VRX) Division Ortho Dermatologics Announces Publication of Pivotal Efficacy and Safety Data for Psoriasis Treatment DUOBRII in the JAAD

Ortho Dermatologics, a division of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), announced that the Journal of the American Academy of Dermatology (JAAD) published for the first …

Valeant Pharmaceuticals Intl Inc’s (VRX) Ortho Dermatologics Division Submits NDA for Psoriasis Treatment

Ortho Dermatologics, a division of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced it has submitted a New Drug Application (NDA) to the FDA for IDP-118 (halobetasol propionate …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts